| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.71 | 0.005 |